MedPath

UNIVERSITY OF ESSEX

🇬🇧United Kingdom
Ownership
-
Established
1965-01-01
Employees
-
Market Cap
-
Website
http://www.essex.ac.uk

Clinical Trials

5

Active:0
Completed:3

Trial Phases

1 Phases

Not Applicable:4

Drug Approvals

0

Drug Approvals

No drug approvals found

This company may not have drug approvals in our database

Clinical Trials

Distribution across different clinical trial phases (4 trials with phase data)• Click on a phase to view related trials

Not Applicable
4 (100.0%)

BCI Driving FES and Hand Orthosis for Upper Limb Rehabilitation in Chronic Stroke

Not Applicable
Recruiting
Conditions
Stroke, Cerebrovascular
Hemiplegia and Hemiparesis
Stroke/Brain Attack
First Posted Date
2023-12-22
Last Posted Date
2023-12-22
Lead Sponsor
University of Essex
Target Recruit Count
32
Registration Number
NCT06179745
Locations
🇮🇹

Ospedale di Vipiteno | Azienda Sanitaria dell'Alto Adige, Vipiteno, South Tyrol, Italy

Understanding and Overcoming the Racial/Ethnic Inequalities in COVID-19 Vaccination Acceptance

Not Applicable
Completed
Conditions
Vaccine Refusal
First Posted Date
2022-02-14
Last Posted Date
2022-05-24
Lead Sponsor
University of Essex
Target Recruit Count
4039
Registration Number
NCT05238428
Locations
🇬🇧

Qualtrics. The data is gathered via an online platform., London, United Kingdom

Managing Achilles Pain II

Recruiting
Conditions
Achilles Tendinopathy
First Posted Date
2021-11-03
Last Posted Date
2023-03-24
Lead Sponsor
University of Essex
Target Recruit Count
159
Registration Number
NCT05105269
Locations
🇬🇧

Connect Health, Newcastle Upon Tyne, Tyne And Wear, United Kingdom

A Feasibility Study to Evaluate Self-Harm Group in Inpatient Settings

Not Applicable
Completed
Conditions
Self-Injurious Behavior
First Posted Date
2017-01-27
Last Posted Date
2018-06-04
Lead Sponsor
University of Essex
Target Recruit Count
24
Registration Number
NCT03035110
Locations
🇬🇧

Goodmayes Hospital, Ilford, Essex, United Kingdom

Ischemia Reperfusion: Prostaglandins and Antioxidants

Not Applicable
Completed
Conditions
Ischemic Reperfusion Injury
Interventions
Dietary Supplement: Antioxidant
Drug: Prostaglandin inhibitor (Ibuprophen)
First Posted Date
2012-08-16
Last Posted Date
2017-05-12
Lead Sponsor
University of Essex
Target Recruit Count
12
Registration Number
NCT01666587
Locations
🇬🇧

University of Essex, Colchester, Essex, United Kingdom

News

No news found

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.